C57BL/6JCya-Ptafrem1flox/Cya
Common Name:
Ptafr-flox
Product ID:
S-CKO-04503
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Ptafr-flox
Strain ID
CKOCMP-19204-Ptafr-B6J-VA
Gene Name
Product ID
S-CKO-04503
Gene Alias
PAFR
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
4
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Ptafrem1flox/Cya mice (Catalog S-CKO-04503) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000070690
NCBI RefSeq
NM_001081211
Target Region
Exon 2
Size of Effective Region
~3.7 kb
Detailed Document
Overview of Gene Research
Ptafr, the platelet-activating factor receptor, is a key component in various biological processes. Platelet-activating factor (PAF) is a phospholipid-derived inflammatory mediator, and Ptafr is involved in PAF-related pathways. Ptafr has pro-inflammatory, pro-coagulant, and angiogenic actions on the vasculature [5]. It is also associated with processes like cell proliferation, fibrosis, and metastasis, highlighting its overall biological importance [1,3,4,6]. Genetic models, such as gene knockout models, can be valuable for studying its functions.
In a TP53/CDKN2A double-knockout gastroesophageal junction organoid model, abrogation of PTAFR by siRNA knockdown or a pharmacologic inhibitor reduced proliferation and proneoplastic features in vitro and tumor formation in vivo. Mechanistically, FOXM1 activated PTAFR transcription by binding to its promoter, amplifying the PTAF-PTAFR pathway [1]. In a mouse model of atherosclerosis, PTAFR was identified as a key gene influencing the progression and prognosis of the disease, regulating neutrophil extracellular traps (NETs) formation [2]. In cardiac fibrosis models, knockdown of PTAFR affected pro-fibrotic collagen production mediated by the lncRNA PFL, and overexpression of PTAFR led to collagen production [3]. In a post-myocardial infarction cardiac fibrosis model, miR-30b-5p and miR-22-3p restrained fibrogenesis by targeting PTAFR [4].
In conclusion, Ptafr plays essential roles in processes like tumorigenesis, atherosclerosis, and cardiac fibrosis. Gene knockout-based research in these areas has revealed that Ptafr is a potential therapeutic target. In tumorigenesis, its inhibition can reduce cancer-promoting features; in atherosclerosis, it impacts disease progression; and in cardiac fibrosis, it is involved in collagen production. Understanding Ptafr's functions through these models provides insights into disease mechanisms and potential treatment strategies.
References:
1. Zhao, Hua, Cheng, Yulan, Kalra, Andrew, Lin, De-Chen, Meltzer, Stephen J. 2022. Generation and multiomic profiling of a TP53/CDKN2A double-knockout gastroesophageal junction organoid model. In Science translational medicine, 14, eabq6146. doi:10.1126/scitranslmed.abq6146. https://pubmed.ncbi.nlm.nih.gov/36449602/
2. Ye, Chaowen, Zhao, Yunli, Yu, Wei, Huang, Rongzhong, Hu, Tianyang. 2024. Identifying PTAFR as a hub gene in atherosclerosis: implications for NETosis and disease progression. In Human genomics, 18, 139. doi:10.1186/s40246-024-00708-3. https://pubmed.ncbi.nlm.nih.gov/39709510/
3. Leisegang, Matthias S. 2018. LET's sponge: How the lncRNA PFL promotes cardiac fibrosis. In Theranostics, 8, 874-877. doi:10.7150/thno.23364. https://pubmed.ncbi.nlm.nih.gov/29463987/
4. Zhao, X-S, Ren, Y, Wu, Y, Ren, H-K, Chen, H. . MiR-30b-5p and miR-22-3p restrain the fibrogenesis of post-myocardial infarction in mice via targeting PTAFR. In European review for medical and pharmacological sciences, 24, 3993-4004. doi:10.26355/eurrev_202004_20869. https://pubmed.ncbi.nlm.nih.gov/32329883/
5. Bhosle, Vikrant K, Rivera, José Carlos, Zhou, Tianwei Ellen, Ribeiro-da-Silva, Alfredo, Chemtob, Sylvain. 2016. Nuclear localization of platelet-activating factor receptor controls retinal neovascularization. In Cell discovery, 2, 16017. doi:10.1038/celldisc.2016.17. https://pubmed.ncbi.nlm.nih.gov/27462464/
6. Cao, Linna, Zhang, Yiwei, Mi, Jinxia, Pan, Zhiqiang, Peng, Peike. 2022. α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression. In Pharmacological research, 178, 106180. doi:10.1016/j.phrs.2022.106180. https://pubmed.ncbi.nlm.nih.gov/35288308/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen